A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BCC / breast cancer cell

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BCC  (>> Co-occurring Abbreviation)
Long Form:   breast cancer cell
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor. BW, EAC
2019 Fatty Acid Synthesis and Degradation Interplay to Regulate the Oxidative Stress in Cancer Cells. FAO, FAS
2019 LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition. EMT, lncRNAs, MSCs
2019 Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer. MMP, MUC, VEGF
2018 Baker's Yeast Sensitizes Metastatic Breast Cancer Cells to Paclitaxel In Vitro. EAC
2018 FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth. ---
2018 Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center. GKH, UICC
2018 LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer. LATS2, MI, mRNA, MSP
2018 Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells. FLP, IHC, Pfn1, TMA
10  2017 E-Selectin and SDF-1 regulate metastatic trafficking of breast cancer cells within the bone. BM, SDF-1
11  2017 Helping Hospitals Improve Patient Centeredness: Assessing the Impact of Feedback Following a Best Practices Workshop. ITS, LOESS, RPD
12  2017 Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells. ALDH, BCSC
13  2017 Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ. CSC, mtp53, WIP, wtp53
14  2017 Suppression of TAFI by siRNA inhibits invasion and migration of breast cancer cells. BC, CPB2, si, TAFI
15  2016 Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs). MSCs
16  2015 Biological roles of human bone morphogenetic protein 9 in the bone microenvironment of human breast cancer MDA-MB-231 cells. BMP9, BMSC, EMT, IL-6, MCP-1, MMP-2, SDF-1
17  2015 Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer. RSS
18  2015 Differentiation of Normal and Cancer Cell Adhesion on Custom Designed Protein Nanopatterns. EBL, NMEC
19  2015 Human Adipose-Derived Mesenchymal Stromal Cells May Promote Breast Cancer Progression and Metastatic Spread. ADMSCs, MCF, MDA, RANTES
20  2015 Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. ASCs, EMT
21  2015 Macrophage migration inhibitory factor involvement in breast cancer (Review). MIF
22  2015 Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells. Cath D, TRPS1
23  2014 A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment. ELIP, NO
24  2014 Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells. CM, ECM
25  2014 Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro. DNR
26  2014 The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions. Ang-2, BBB, BMECs, HBMECs, SP, TJ, TNF-alpha
27  2013 Economic constraints - the growing challenge for Western breast cancer centers. ---
28  2013 Radiation-induced myosin IIA expression stimulates collagen type I matrix reorganization. BC, Col I, ECM, FAK, RI
29  2013 The perivascular niche regulates breast tumour dormancy. DTCs
30  2013 Tumor-stroma interaction: Revealing fibroblast-secreted exosomes as potent regulators of Wnt-planar cell polarity signaling in cancer metastasis. CAF, PCP
31  2012 Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. PCP
32  2011 Reassessment of estrogen receptor expression in human breast cancer cell lines. ER, FCM, RT-PCR, WB
33  2010 17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production. DHT
34  2010 Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. EMT, HMEC, MeDIP-seq
35  2007 High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. IHMEC
36  2006 A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. CCND1, ERalpha
37  2005 Cell cycle regulation of breast cancer cells through estrogen-induced activities of ERK and Akt protein kinases. ER
38  2005 Ingenol derivatives inhibit proliferation and induce apoptosis in breast cancer cell lines. ---
39  2005 Synergistic role of arabinoxylan rice bran (MGN-3/Biobran) in S. cerevisiae-induced apoptosis of monolayer breast cancer MCF-7 cells. ---
40  2004 About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. ER-alpha
41  2004 Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes. ERalpha, PKC, PMA
42  2004 Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro. ---
43  2004 Relevance of breast cancer cell lines as models for breast tumours: an update. ---
44  2000 Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. BM, OCL
45  2000 Protein production by osteoblasts: modulation by breast cancer cell-derived factors. MMPs, TIO
46  1999 Epigenetic regulation of gelsolin expression in human breast cancer cells. 5-aza, HMEC, MDA-231, TSA
47  1999 The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. IL-6, INDO, SA
48  1999 Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry. BC, CEA, CK19, IC, LP, RT-PCR
49  1998 Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation. 5-FC, 5-FU, BCCs, CD, CMV, FACS, HMECs, PBMCs
50  1998 Production and regulation of interleukin-11 by breast cancer cells. IL-11, IL-6
51  1997 Regulation of c-fos and c-jun expression by calcitonin in human breast cancer cells. CT, EGF, PKA, PKC, PMA, TIMP
52  1997 TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. ERK2, MAPKs, PAI-1, SAPK/JNK, TGF-beta2
53  1995 Patient evaluation of care within a multidisciplinary breast care center. ---
54  1993 Benefits of a multidisciplinary approach to breast care. ---
55  1990 Training obstetrics-and-gynecology residents to manage breast disease. Incorporation into a breast care clinic. ---
56  1987 Developing a comprehensive breast center. ---